Brain Scans Reveal How the Endocannabinoid System Changes in Psychiatric Disorders
A review of PET imaging studies shows that the brain's endocannabinoid system is altered in cannabis use disorder, alcoholism, PTSD, schizophrenia, and eating disorders — each in distinct ways.
Quick Facts
What This Study Found
PET imaging reveals distinct alterations in endocannabinoid system components across psychiatric conditions. The review summarizes available PET tracers targeting CB1 receptors, FAAH, MAGL, and other ECS components, and their findings across cannabis use disorder, alcohol use disorder, PTSD, schizophrenia, and eating disorders.
Key Numbers
Disorders covered: cannabis use disorder, alcohol use disorder, PTSD, schizophrenia, eating disorders. ECS components imaged: CB1 receptors, FAAH, MAGL, and others. Multiple PET tracers reviewed for each target.
How They Did This
Narrative review of PET tracer development and clinical application studies. Covers multiple ECS-targeting radiotracers and their use in diverse psychiatric populations. Synthesizes findings across different ECS components and disorders.
Why This Research Matters
PET imaging allows researchers to see the endocannabinoid system working in living brains for the first time. Understanding how this system changes in different psychiatric disorders could lead to more targeted cannabinoid-based treatments.
The Bigger Picture
The endocannabinoid system is emerging as a common thread across multiple psychiatric disorders, but each condition shows unique patterns of disruption. This suggests cannabinoid-based treatments may need to be tailored to specific disorders rather than using a one-size-fits-all approach.
What This Study Doesn't Tell Us
Narrative review format (not systematic). PET studies typically have small sample sizes and are expensive. Most tracers are still research tools, not clinically available. Cross-study comparison is complicated by different tracers and methods.
Questions This Raises
- ?Can ECS PET imaging become a diagnostic tool for psychiatric disorders?
- ?Would these imaging findings help select which patients might benefit from cannabinoid therapies?
- ?How do ECS changes progress over time in each disorder?
Trust & Context
- Key Stat:
- Evidence Grade:
- Comprehensive narrative review of an emerging imaging field, but individual PET studies tend to be small and methodology varies.
- Study Age:
- Published in 2026, capturing the latest advances in endocannabinoid system PET imaging.
- Original Title:
- PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders.
- Published In:
- Neuroscience bulletin, 42(2), 419-438 (2026)
- Authors:
- Cui, Chunyi, Dou, Xiaofeng, Cen, Peili, Jin, Chentao, Wang, Jing, Niu, Jiaqi, Xue, Chenxi, Tian, Mei, Zhang, Hong, Zhong, Yan
- Database ID:
- RTHC-08193
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Can brain scans show how cannabis affects the brain?
Yes — PET scans can now image the endocannabinoid system in living brains, showing how CB1 receptors and related enzymes change with cannabis use and in various psychiatric disorders.
Is the endocannabinoid system involved in mental health conditions?
This review shows distinct ECS alterations in cannabis use disorder, alcoholism, PTSD, schizophrenia, and eating disorders — suggesting it plays a role in multiple psychiatric conditions, though in different ways.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-08193APA
Cui, Chunyi; Dou, Xiaofeng; Cen, Peili; Jin, Chentao; Wang, Jing; Niu, Jiaqi; Xue, Chenxi; Tian, Mei; Zhang, Hong; Zhong, Yan. (2026). PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders.. Neuroscience bulletin, 42(2), 419-438. https://doi.org/10.1007/s12264-025-01515-z
MLA
Cui, Chunyi, et al. "PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders.." Neuroscience bulletin, 2026. https://doi.org/10.1007/s12264-025-01515-z
RethinkTHC
RethinkTHC Research Database. "PET Molecular Imaging of the Endocannabinoid System in Psych..." RTHC-08193. Retrieved from https://rethinkthc.com/research/cui-2026-pet-molecular-imaging-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.